Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy.
[vc_row][vc_column]
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy.
After successful operational results from its Collection Sites subsidiary, which includes the sale of 73,973 tests at an average price of $96 in January, Medivolve is initiating an investor awareness campaign.
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy. Further, Tim Shelburn is stepping down from his executive role at Collection Sites.
Medivolve Also Strengthens its Balance Sheet via Shares for Debt Settlements.
To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday, February 4th at 1 pm ET.
Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that convertsinto a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a webinar Thursday, February 4 th at 1 pm ET.
Medivolve will host a webinar Thursday, February 4th at 1 pm ET. This includes an overview of Collection Sites’ network growth and a presentation from the UCLA researchers behind the Marvel Diagnostics innovative BlowFISH Technology for the detection of the presence of the COVID-19 virus.
Marvel Diagnostics innovative BlowFISH technology offers the potential for a a simple,
inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats.
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO – January 25, 2021 (GLOBE NEWSWIRE) Medivolve, Inc. (“Medivolve”)
(NEO:MEDV; OTC:COPRF; FRA:4NC) released a statement on the passing of its strategic
advisor, Larry King. With great sadness, we honor the death of our advisor and friend.
Collection Sites and Celebrity Heidi Powell Opens Two Covid-19 Testing Centers – Gives Away Free 30-day Subscription to The Transform App and Provides Access to Innovative Fitness and Nutrition Content to Help People Strengthen and Maintain Healthy Bodies